(b)(4).Concomitant medical products- oxf twin peg cmntls fmrl md , item 161474, lot r2503468a, therapy date - device remains implanted, oxford cementless tibia d lm , item us166576, lot r3050478a, therapy date - device remains implanted.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.Multiple mdr reports were filed for this event, please see associated reports: 3002806535-2018-01197 and 3002806535-2018-01199.
|
(b)(4).Reported event was confirmed by review of x-rays provided: there is a thin radiolucent line present beneath the tibial tray.The oxford surgical technique states: 'histologically, the radiolucent line represents a layer of fibrocartilage, with its collagen organized parallel with the plateau.The radiodense line represents a new ¿subchondral bone plate.¿ the trabeculae, which were cut at the operation, attach to this plate and support it.The collagen fibers of the cartilage layer insert into its upper surface.There are some areas within the radiolucency in which there is direct contact between cement and bone.¿the radiographic changes which occur during the first postoperative year result from healing of the cut bone and its remodeling to sustain the new pattern of compressive load applied to it by the rigid implant.A review of oxford partial knee patients found no relationship between the presence of radiolucent lines and clinical outcomes.[gulati et al 2009]' the manufacturing history records (mhrs) for the oxford partial knee femoral, tibial and bearing components have been checked and verify that the components were manufactured and sterilised correctly.There is no indication that the reported adverse event is related to the function of the device.Zimmer biomet will continue to monitor for trends.
|